| Type : |
Journal |
| Internet-link : |
http://dx.doi.org/10.1136/ejhpharm-2016-000913 |
|
| forskerhold : |
Nablus - An-Najah National University, Faculty of Medicines and Health Sciences |
| Forfattere : |
Zaid A.N, Assali M, Zalmout S, Basheer A. |
| Titel : |
Compounding and stability evaluation of atorvastatin extemporaneous oral suspension using tablets or pure powder. |
| Nummer : |
EJHP ; 24: 157-161. 2016 |
|
| cotationvaleur : |
|
| fysisk stabilitet : |
|
| kemisk stabilitet : |
|
| andre metoder : |
|
| Kommentarer : |
|
Lister
 Atorvastatine
|
 |
 |
 |
 |
400 mg
Lipitor® |
| xanthangummi |
50 mg |
| Pebermynteolie |
50 mg |
| natriumphosphat |
300 mg |
| Sukrose |
40 g |
| Vand til injektion |
>> 100 mL |
|
2-8°C |
 |
| 30 |
 |
|
|
|
|
|
400 mg
Lipovast® |
| xanthangummi |
50 mg |
| Pebermynteolie |
50 mg |
| natriumphosphat |
300 mg |
| Sukrose |
40 g |
| Vand til injektion |
>> 100 mL |
|
2-8°C |
|
| 30 |
|
|
|
|
|
|
400 mg
Lipovast® |
| xanthangummi |
50 mg |
| Pebermynteolie |
50 mg |
| natriumphosphat |
300 mg |
| Sukrose |
40 g |
| Vand til injektion |
>> 100 mL |
|
25°C |
|
| 30 |
|
|
|
|
|
|
400 mg
Lipitor® |
| xanthangummi |
50 mg |
| Pebermynteolie |
50 mg |
| natriumphosphat |
300 mg |
| Sukrose |
40 g |
| Vand til injektion |
>> 100 mL |
|
25°C |
|
| 30 |
|
|
|
|
|
